Rytelo Prices, Coupons, Copay Cards & Patient Assistance
Rytelo (imetelstat) is a member of the miscellaneous antineoplastics drug class and is commonly used for Myelodysplastic Syndrome.
The cost for Rytelo 47 mg intravenous powder for injection is around $2,727 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Rytelo is available as a brand name drug only, a generic version is not yet available. View generic Rytelo availability for more details.
Rytelo prices
Intravenous Powder For Injection
47 mg
Rytelo intravenous powder for injection
from $2,726.98
for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $2,726.98 | $2,726.98 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
188 mg
Rytelo intravenous powder for injection
from $10,877.91
for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $10,877.91 | $10,877.91 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Rytelo Coupons, Copay Cards and Rebates
Rytelo offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Rytelo Copay Program
Eligible commercially insured patients may pay as little as $0 out-of-pocket for RYTELO, which includes copay and coinsurance, up to $9450 annually.
- Applies to:
- Rytelo
- Number of uses:
- Per length of program
Form more information phone: 844-479-8356 or Visit website
REACH4RYTELO Copay Program
Eligible commercially insured patients may save up to $10,650 per calendar year for RYTELO.
- Applies to:
- Rytelo
- Number of uses:
- Per length of program
Form more information phone: 844-479-8356 or Visit website
Patient Assistance & Copay Programs for Rytelo
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Rytelo (imetelstat) Injection for Intravenous use
More information please phone: 800-675-8416 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Rytelo (imetelstat) Injection for Intravenous use
More information please phone: 866-316-7263 Visit Website
Provider: Reach4Rytelo Patient Support Program
Eligibility requirements:- Must be uninsured or rendered uninsured
- Not disclosed
- FDA-approved diagnosis
- Must be residing in the US or US territory
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Rytelo (imetelstat) Injection for Intravenous use
More information please phone: 844-479-8356 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Reblozyl
Reblozyl is used to treat anemia in adults with beta-thalassemia or myelodysplastic syndromes ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Dacogen
Dacogen (decitabine) is used to treat myelodysplastic syndromes (certain types of blood or bone ...
Inqovi
Inqovi (decitabine and cedazuridine) is used for the treatment of myelodysplastic syndromes (MDS) ...
Onureg
Onureg (azacitidine) is used for the continued treatment of adult patients with acute myeloid ...
Decitabine
Decitabine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Ivosidenib
Ivosidenib systemic is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Luspatercept
Luspatercept (brand name Reblozyl) is used to treat anemia (low red blood cells) in certain ...
More about Rytelo (imetelstat)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
